LADENBURG THALMANN FINANCIAL SERVICES INC. - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 159 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$15,000
+50.0%
324
+4.5%
0.00%
Q3 2019$10,000
-33.3%
3100.0%0.00%
Q2 2019$15,000
-34.8%
310
-7.2%
0.00%
Q1 2019$23,000
+53.3%
334
+2.8%
0.00%
Q4 2018$15,000
+1400.0%
325
+3150.0%
0.00%
Q3 2018$1,000
-88.9%
10
-93.3%
0.00%
Q1 2017$9,000
+80.0%
150
+18.1%
0.00%
Q2 2016$5,000
-54.5%
127
-53.3%
0.00%
Q1 2016$11,000
-15.4%
272
+34.7%
0.00%
Q4 2015$13,000
-7.1%
202
-1.5%
0.00%
Q3 2015$14,000
-39.1%
205
-2.8%
0.00%
Q2 2015$23,000
+15.0%
2110.0%0.00%
Q1 2015$20,000
+150.0%
211
+197.2%
0.00%
Q4 2014$8,000
+100.0%
710.0%0.00%
Q3 2014$4,000
+33.3%
710.0%0.00%
Q2 2014$3,000710.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
BB BIOTECH AG 2,719,998$155,502,0004.38%
Casdin Capital, LLC 295,000$16,865,0004.11%
Opaleye Management Inc. 130,000$7,432,0002.38%
Opus Point Partners Management, LLC 28,704$1,641,0001.42%
Fernwood Investment Management, LLC 27,550$1,575,0000.84%
Rhenman & Partners Asset Management AB 100,000$5,717,0000.77%
COLUMBIA WANGER ASSET MANAGEMENT LLC 760,116$43,456,0000.65%
Eventide Asset Management 214,000$12,234,0000.64%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 262,984$15,035,0000.59%
CAPITAL GUARDIAN TRUST CO 663,089$37,909,0000.54%
View complete list of AGIOS PHARMACEUTICALS INC shareholders